The new coronavirus infection (COVID-19) has become a pandemic, spread all over the world, and our lives have changed dramatically. Since the beginning of the pandemic in January 2020, The International Society for Orthomolecular Medicine (ISOM) and Orthomolecular Medicine News Services (OMNS) have provided healthcare professionals and the general public with information on the prevention and treatment of COVID-19 using orthomolecular nutrition approach… [READ MORE]
This resource includes a selection of research publications pertaining to micronutrients and their biological roles in immune function. Articles are linked to their original source via Digital Object Identifier (DOI); PubMed Identifier (PMID); or Uniform Resource Locator (URL)
03.03.2020 – ISOM Press Conference – Tokyo, Japan . ORTHOMOLECULAR PREVENTION AND TREATMENT FOR NEW CORONAVIRUS COVID-19 INFECTION . Presenter: Atsuo Yanagisawa, MD, PhD – President, International Society for Orthomolecular Medicine .
ISOM President Dr. Atsuo Yanagisawa, MD, PhD, held a press conference in Tokyo, Japan, on March 3, 2020. The information disseminated to the media and health care professionals focused on oral dosing of specific micronutrients recommended by the International Society for Orthomolecular Medicine (ISOM) for the prevention and treatment of COVID-19. Presentation in Japanese with English subtitles. This video is also available on YouTube
VIEW PRESS CONFERENCE
04.08.2020 – NIH Webinar . VITAMIN C IN THE TREATMENT AND PREVENTION OF COVID-19 .
Presenter: Richard Cheng, MD, PhD . Abstract: This presentation focuses on the role of vitamin C in the treatment and prevention of COVID-19. Current research and preliminary results from clinical trials and practical applications are discussed. Dr. Richard Cheng, MD, PhD, has played an integral role in the development of treatment guidelines currently being used in critical care settings in China. . This resource is intended for health care professionals.
03.19.2020 – ISOM Webinar . VITAMIN C FOR THE TREATMENT OF CORONAVIRUS (COVID-19) .
Presenter: Paul S. Anderson, NMD . Abstract: This presentation focuses on the role of ascorbate (vitamin C) in the treatment of COVID-19 and its potentially fatal sequela. Pharmacokinetics, safety, and the current scientific literature are reviewed. Clinical applications of oral and intravenous vitamin C are discussed in the context of viral illness. . This resource is intended for health care professionals.
Front Line Critical Care COVID-19 Working Group . EARLY INTERVENTION PROTOCOL FOR COVID-19 CAN SAVE LIVES . This video describes the work of critical care specialists who are treating coronavirus patients at academic centers and other major hospitals across the United States. Through their current work, past research, and studying the findings of the Shanghai expert protocols, they have concluded that a combination of corticosteroids, high dose intravenous ascorbic acid (vitamin C), and anticoagulants, given early in the ER or hospital, can prevent the progression of the disease and reduce the need for mechanical ventilators. Their findings have not yet been widely adopted in the U.S. and they want to get the word out to save lives now. .
06.02.2019 – 48th Annual International Orthomolecular Medicine Today Conference – Vancouver, Canada . AN ORTHOMOLECULAR APPROACH TO PREVENTING AND TREATING INFLUENZA . Presenter: Aileen Burford-Mason, PhD . Abstract: Immune function is controlled through nutrient-dependent metabolic pathways and the presence of multiple nutrients that are essential to these pathways is a prerequisite to mounting an effective antiviral defence. On average, 5-20% of North Americans succumb to influenza annually, involving 30 million doctor visits and 200,000 hospitalizations. Although vaccination reduces incidence, it does not offer total protection, and efficacy varies from a low of 10% (2004-5) to a high of 60% (2010-11). Evidence suggests that correcting common shortfalls of vitamins, minerals and other nutrients can enhance immune responses to infection and complement current public health approaches to mitigate the incidence and severity of seasonal influenza.
04.02.2020 – RxISK.org . MEDICATIONS COMPROMISING COVID INFECTIONS . Author: Joan-Ramon Laporte, MD . Consumption of various commonly used medicines can increase the risk of pneumonia or pneumonitis by depressing immunity and other protective mechanisms (e.g., immunosuppressive agents, antipsychotic agents, some opioid analgesics, proton pump inhibitors), by causing sedation, which may increase the risk of aspiration, by depressing pulmonary ventilation and favouring the occurrence of atelectasis (e.g., opioid analgesics, anticholinergic drugs, psychotropic agents), or by a combination of these mechanisms. . Translation link: Español
VIEW RxISK DOCUMENT
. DISCLAIMER OF INFORMATION & CONTENT
This website contains information pertaining to nutritional intervention and the use of non-patentable molecules for improving outcomes in various medical conditions. The information provided may not reflect the current standard(s) of care in your jurisdiction, and is not intended to be a substitute for medical advice from a licensed physician or other qualified health care professional.
Please consult your regional public health authority for specific guidelines and resources pertaining to the prevention of SARS-CoV-2 / COVID-19